Hirotaka Watada Selected Research

Glycemic Control

5/2024	Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial.
2/2024	Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in Japan.
1/2024	Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists-Secondary publication.
1/2024	Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publication.
6/2023	A 7 day inpatient diabetes education program improves quality of life and glycemic control 12 months after discharge.
11/2020	Effect of real-life insulin pump with predictive low-glucose management use for 3 months: Analysis of the patients treated in a Japanese center.
11/2020	Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan.
1/2020	IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy.
11/2018	Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study.
4/2018	Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirotaka Watada Research Topics

Disease

151	Type 2 Diabetes Mellitus (MODY) 05/2024 - 07/2002
55	Insulin Resistance 01/2024 - 05/2003
32	Atherosclerosis 12/2023 - 04/2004
26	Body Weight (Weight, Body) 11/2023 - 12/2005
25	Hypoglycemia (Reactive Hypoglycemia) 02/2024 - 08/2004
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 06/2006
20	Hyperglycemia 01/2021 - 06/2005
12	Hypertension (High Blood Pressure) 01/2024 - 04/2007
12	Diabetes Mellitus 11/2023 - 06/2005
10	Carotid Artery Diseases 01/2023 - 10/2006
9	Glucose Intolerance 01/2024 - 01/2002
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2003
8	Albuminuria 01/2023 - 03/2003
7	Chronic Renal Insufficiency 04/2024 - 01/2020
7	Weight Gain 01/2023 - 12/2009
7	Inflammation (Inflammations) 12/2022 - 10/2006
6	Neoplasms (Cancer) 01/2024 - 03/2017
6	Weight Loss (Weight Reduction) 01/2022 - 08/2007
5	Heart Failure 01/2023 - 01/2014
5	Dementia (Dementias) 04/2021 - 11/2013
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 04/2010
4	Sarcopenia 01/2024 - 12/2022
4	Dyslipidemias (Dyslipidemia) 09/2023 - 01/2014
4	Graves Disease (Basedow Disease) 01/2023 - 10/2014
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 08/2007
4	Obesity 09/2021 - 06/2006
4	Thyrotoxicosis 12/2017 - 01/2014
4	Stroke (Strokes) 01/2015 - 04/2009
3	Starvation 04/2024 - 01/2019
3	Fibrosis (Cirrhosis) 09/2023 - 06/2006
3	Prediabetic State (Prediabetes) 12/2022 - 01/2015
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 10/2019
2	Kidney Diseases (Kidney Disease) 04/2024 - 04/2020
2	Osteophyte 12/2023 - 09/2023
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2023 - 01/2020
2	Endotoxemia 06/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

97	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2002
80	Insulin (Novolin)FDA Link 11/2023 - 05/2003
26	LipidsIBA 02/2024 - 06/2005
21	Hypoglycemic Agents (Hypoglycemics)IBA 11/2023 - 08/2004
17	Sitagliptin Phosphate (Januvia)FDA Link 06/2019 - 03/2014
15	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2023 - 01/2013
15	Blood Glucose (Blood Sugar)IBA 05/2021 - 02/2006
13	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 03/2014
10	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 01/2023 - 03/2014
10	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2022 - 09/2008
10	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2021 - 07/2013
9	Triglycerides (Triacylglycerol)IBA 01/2024 - 06/2006
9	LinagliptinIBA 09/2020 - 07/2011
8	Nonesterified Fatty Acids (NEFA)IBA 01/2024 - 06/2005
8	SodiumIBA 12/2022 - 03/2014
8	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 04/2007
7	Glucagon (Glukagon)FDA Link 11/2023 - 12/2012
7	alogliptinIBA 01/2023 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2014
6	Sodium-Glucose Transport ProteinsIBA 01/2023 - 04/2014
6	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 04/2007
6	Insulin Glargine (Lantus)FDA Link 01/2020 - 02/2006
6	Nateglinide (Starlix)FDA LinkGeneric 09/2015 - 08/2004
5	Pioglitazone (Actos)FDA Link 01/2015 - 01/2009
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2015
4	Protons (Proton)IBA 12/2023 - 01/2013
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 05/2008
4	Hormones (Hormone)IBA 01/2023 - 09/2014
4	CreatinineIBA 01/2023 - 03/2003
4	AlbuminsIBA 01/2023 - 04/2009
4	insulin degludecIBA 01/2023 - 01/2015
4	IodineIBA 01/2023 - 11/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 04/2005
4	voglibose (Basen)IBA 06/2018 - 04/2006
4	Glycoside Hydrolase InhibitorsIBA 05/2016 - 07/2007
3	empagliflozinIBA 04/2024 - 04/2016
3	imegliminIBA 11/2023 - 01/2022
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2022 - 02/2011
3	CanagliflozinIBA 01/2022 - 04/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2016
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 02/2011
3	semaglutideIBA 12/2021 - 01/2018
3	IDegLiraIBA 09/2021 - 12/2019
3	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2021 - 10/2014
3	EnzymesIBA 01/2021 - 03/2017
3	PotassiumIBA 01/2021 - 04/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2009
3	AdiponectinIBA 01/2021 - 01/2017
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 01/2018
3	firuglipelIBA 01/2019 - 01/2018
3	VildagliptinIBA 12/2017 - 07/2014
3	Insulin Lispro (Humalog)FDA Link 07/2017 - 01/2017
3	Acarbose FDA LinkGeneric 05/2016 - 06/2006
3	Long-Acting Thyroid Stimulator (LATS)IBA 01/2016 - 10/2014
3	Transcription Factors (Transcription Factor)IBA 11/2015 - 01/2002
3	ApolipoproteinsIBA 01/2015 - 07/2007
3	Atorvastatin (Lipitor)FDA Link 05/2013 - 06/2005
3	candesartanIBA 04/2007 - 06/2006
3	Angiotensin II Type 1 Receptor BlockersIBA 04/2007 - 06/2006
2	lipopolysaccharide-binding proteinIBA 06/2023 - 01/2019
2	CalciumIBA 01/2023 - 12/2022

Therapy/Procedure

52	Therapeutics 01/2024 - 12/2004
39	Glycemic Control 05/2024 - 08/2004
3	Exercise Therapy (Therapy, Exercise) 06/2018 - 06/2005